Matthew Rausch

2PUBLICATIONS
6CO-AUTHORS
Human impacts of climate change and human adaptationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 23, 2023
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.

Michael C Warren, Stephan Matissek, Matthew Rausch

|Apr 10, 2020
GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.

Matthew P Rausch, Lydia R Meador, Todd C Metzger

Pageof 1